Vimarsana
Biggest News Aggregation in the World

Page 2 - Research Update Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Update Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Update Study Today - Breaking & Trending Today

Kinarus Therapeutics Holding AG: Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan - Vimarsana News

Kinarus Therapeutics Holding AG: Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan

Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study results Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan 17.01.2023

Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Pl - Vimarsana News

Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Pl

Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study resultsKinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan 17.01.2023 / 07:00 CET/CESTMEDIA RELEASE KIN001 reduced fibrotic damage of the lung in a preclinical fibrosis model Potential as an effe...

​​​​​​​Pareto Securities AS publishes buy recommendation for Epigenomics AG share - Vimarsana News

​​​​​​​Pareto Securities AS publishes buy recommendation for Epigenomics AG share

EQS-News: Epigenomics AG / Key word(s): Research Update/Study results​​​​​​​Pareto Securities AS publishes buy recommendation for Epigenomics AG share 23.12.2022 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Pareto Securities AS publishes buy recommendation for Epigenomics AG...

Spexis announces promising pre-clinical data with balixafortide in combination with various therapie - Vimarsana News

Spexis announces promising pre-clinical data with balixafortide in combination with various therapie

Spexis AG / Key word(s): Research Update/Study resultsSpexis announces promising pre-clinical data with balixafortide in combination with various therapies on the market for treating B-cell lymphomas 13.12.2022 / 07:30 CET/CESTAllschwil, Switzerland, December 13, 2022 Spexis announces promising pre-clinical dat...

Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients - Vimarsana News

Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients

Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in...